Author:
Batlle J.,Lasierra J.,Villamor A. F.,Navarro J. L.,Pardo A.,Campos M.,Justiça B.,López Fernández M. F.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference22 articles.
1. Baruch D, Bahnak B, Girma JP, Meyer D (1989) Von Willebrand factor and platelet function. Baillieres Clin Haematol 2:627–672
2. Batlle J, López Fernández MF (1989) Laboratory assays for von Willebrand factor. In: Zimmerman TS, Ruggeri ZM (eds) Coagulation and bleeding disorders. The role of factor VIII and von Willebrand factor. Marcel Dekker, New York, pp 325–342
3. Batlle J, López Fernández MF, Campos M, Justiça B, Berges C, Navarro JL, Diaz Cremades JM, Kasper CK, Dent JA, Ruggeri ZM, Zimmerman TS (1986) The heterogeneity of type-IIA von Willebrand's disease: studies with proteinase inhibitors. Blood 68:1207–1212
4. Berkowitz SD, Dent J, Roberts JR, Fujimura Y, Plow EF, Titani K, Ruggeri ZM, Zimmerman TS (1987) Epitope mapping of von Willebrand factor subunit distinguishes fragments present in normal and IIA von Willebrand disease from those generated by plasmin. J Clin Invest 79:524–531
5. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM (1990) Identification of a cleavage site directing the immuno-chemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 87:6306–6310
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. C1272F: a novel type 2A von Willebrand’s disease mutation in A1 domain; its clinical significance;Haemophilia;2011-05-18
2. Dominant von Willebrand Disease Type 2A Groups I and II due to Missense Mutations in the A2 Domain of the von Willebrand Factor Gene: Diagnosis and Management;Acta Haematologica;2009
3. Intravenous DDAVP and Factor VIII-von Willebrand Factor Concentrate for the Treatment and Prophylaxis of Bleedings in Patients With von Willebrand Disease Type 1, 2 and 3;Clinical and Applied Thrombosis/Hemostasis;2007-01
4. Classification and Characterization of Hereditary Types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (Unclassifiable) von Willebrand Disease;Clinical and Applied Thrombosis/Hemostasis;2006-10
5. Guidelines for the Evaluation of Intravenous Desmopressin and von Willebrand Factor/Factor VIII Concentrate in the Treatment and Prophylaxis of Bleedings in von Willebrand Disease Types 1, 2, and 3;Seminars in Thrombosis and Hemostasis;2006-09